Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: Results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia syndrome Evaluation

Clinical Cardiology

Volumn 32, Issue 5, 2009, Pages 244-250

  Arant, Christopher B ^a   Wessel, Timothy R ^a   Ridker, Paul M ^b   Olson, Marian B ^c   Reis, Steven E ^c   Johnson, B Delia ^c   Sharaf, Barry L ^d   Pauly, Daniel F ^a   Handberg, Eileen ^a   Zineh, Issam ^a   Sopko, George ^e   Kelsey, Sheryl F ^c   Merz, C Noel Bairey ^f   Pepine, Carl J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HEMOGLOBIN; INTERLEUKIN 6;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART EJECTION FRACTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MORTALITY; PROGNOSIS; PROTEIN BLOOD LEVEL; WOMEN'S HEALTH;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; HEMOGLOBINS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); PROGNOSIS; RISK FACTORS; SERUM AMYLOID A PROTEIN; SEX FACTORS; STROKE VOLUME; SYNDROME; UNITED STATES; VENTRICULAR FUNCTION, LEFT;

EID: 66249128628     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20454     Document Type: Article

References (18)

1. Ross R: Atherosclerosis is an inflammatory disease. Am Heart J. 1999;138:S419-420.
2. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843. (Pubitemid 30165206)
3. Cesari M, Penninx BW, Newman AB, Kritcheversusky SB, Nicklas BJ, et al.: Inflammatory markers and onset of cardiovascular events: Results from the Health ABC study. Circulation. 2003;108:2317-2322. (Pubitemid 37413536)
4. Morrow DA, Braunwald E: Future of biomarkers in acute coronary syndromes: Moving toward a multimarker strategy. Circulation. 2003;108:250-252. (Pubitemid 36899010)
5. Kosiborod M, Smith GL, Radford MJ, Foody JM, Krumholz HM: The prognostic importance of anemia in patients with heart failure. Am J Med. 2003;114:112-119. (Pubitemid 36183592)
6. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM: Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345:1230-1236.
7. Al Falluji N, Lawrence-Nelson J, Kostis JB, Lacy CR, Ranjan R, et al.: Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J. 2002;144:636-641.
8. Arant CB, Wessel TR, Olson MB, Bairey Merz CN, Sopko G, et al.: Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: Results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol. 2004;43:2009-2014. (Pubitemid 38686794)
9. Merz CN, Kelsey SF, Pepine CJ, Reichek N, Reis SE, et al.: The Women's Ischemia Syndrome Evaluation (WISE) study: Protocol design, methodology and feasibility report. J Am Coll Cardiol. 1999;33:1453-1461.
10. Sharaf BL, Pepine CJ, Kerensky RA, Reis SE, Reichek N, et al.: Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). Am J Cardiol. 2001;87:937-941; A3. (Pubitemid 32299974)
11. Rifai N, Joubran R, Yu H, Asmi M, Jouma M: Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem. 1999;45:1967-1973. (Pubitemid 29522005)
12. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, et al.: Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: Prospective analysis from the Women's Health Initiative observational study. JAMA. 2002;288:980-987.
13. Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, et al.: Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1998;98:839-844.
14. Wiviott SD, Cannon CP, Morrow DA, Murphy SA, Gibson CM, et al.: Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: A TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation. 2004;109:580-586. (Pubitemid 38198864)
15. Burke AP, Kolodgie FA, Virmani R: Gender differences in coronary plaque morphology in sudden coronary death: Role of microembolization. Circulation. 2003;108:165A.
16. Reis SE, Holubkov R, Lee JS, Sharaf B, Reichek N, et al.: Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol. 1999;33:1469-1475.
17. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, et al.: Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol. 1990;65:297-302. (Pubitemid 20038909)
18. Yasojima K, Schwab C, McGeer EG, McGeer PL: Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol. 2001;158:1039-1051. (Pubitemid 32221796)